Dual antiplatelet agent failure: A new syndrome or clinical nonentity?
- 1 October 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 154 (4) , 732-735
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary InterventionJACC, 2006
- Aspirin and clopidogrel resistance: an emerging clinical entityEuropean Heart Journal, 2005
- Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- Prior Aspirin Use and Outcomes in Elderly Patients Hospitalized With Acute Myocardial InfarctionJACC, 2005
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJACC, 2003
- The thrombolysis in myocardial infarction risk score in unstable angina/non–ST-segment elevation myocardial infarctionJACC, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary ArticleCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998